Celera, ABI venture data on genetic markers released

EmilyChurch

LONDON (CBS.MW) -- Celera Diagnostics said it presented data in Japan on several novel genetic markers associated with an increased risk for myocardial infarction, or heart attack. CS is a joint venture between Applera Corp's Applied Biosystems Group
ABI, +0.00%
and Celera Genomics Group
CRA, -1.59%
CD said it "intends to complete further statistical analysis of the data from this study in order to evaluate the diagnostic and therapeutic potential of these markers."

Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.